Biomarkers in chronic graft-versus-host disease

Por Rozmus, Jacob, Schultz, Kirk R
Publicado em 2011

Chronic Graft Versus Host Disease (GVHD) in Children

Por Baird, Kristin, Cooke, Kenneth, Schultz, Kirk R.
Publicado em 2010

Pediatric chronic myeloid leukemia is a unique disease that requires a different approach

Por Hijiya, Nobuko, Schultz, Kirk R., Metzler, Markus, Millot, Frederic, Suttorp, Meinolf
Publicado no Blood (2016)

Chronic Graft-versus-Host Disease - Implementation of the National Institutes of Health Consensus Criteria for Clinical Trials

Por Griffith, Linda M., Pavletic, Steven Z., Lee, Stephanie J., Martin, Paul J., Schultz, Kirk R., Vogelsang, Georgia B.
Publicado em 2008

Early and Late Extensive Chronic Graft-Versus-Host Disease (cGVHD) In Children Is Characterized By Different Th1/Th2 Cytokine Profiles: Findings Of The Children’s Oncology Group St...

Por Rozmus, Jacob, Schultz, Kirk R., Wynne, Kristin, Kariminia, Amina, Satyanarayana, Preeti, Krailo, Mark, Grupp, Stephan A., Gilman, Andrew L., Goldman, Frederick D.
Publicado em 2011

Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph(+)ALL: a Children’s Oncology Group (COG) study

Por Chang, Bill H, Willis, Stephanie G, Stork, Linda, Hunger, Stephen P, Carroll, William L, Camitta, Bruce M, Winick, Naomi J, Druker, Brian J, Schultz, Kirk R
Publicado no Br J Haematol (2012)

Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss

Por Medyouf, Hind, Gao, Xiuhua, Armstrong, Florence, Gusscott, Samuel, Liu, Qing, Gedman, Amanda Larson, Matherly, Larry H., Schultz, Kirk R., Pflumio, Francoise, You, Mingjian James, Weng, Andrew P.
Publicado em 2010

Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia

Por Kariminia, Amina, Ivison, Sabine M., Leung, Vivian M., Sung, Susanna, Couto, Nicole, Rozmus, Jacob, Rolf, Nina, Narendran, Aru, Dunn, Sandra E., Reid, Gregor S.D., Schultz, Kirk R.
Publicado no Oncol Lett (2017)

Anti-CD13 antibodies in children with extensive chronic graft-versus-host disease and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Childr...

Por Cuvelier, Geoff D.E., Kariminia, Amina, Fujii, Hisaki, Aslanian, Soudabeh, Wall, Donna, Goldman, Fred, Grupp, Stephan A., Dunn, Sandra E., Krailo, Mark, Shapiro, Linda H., Gilman, Andrew, Schultz, Kirk R.
Publicado em 2010

HLA-matched Sibling Transplantation for Severe Aplastic Anemia: Impact of HLA DR15 Antigen Status on Engraftment, Graft vs. Host Disease and Overall Survival

Por Battiwalla, Minoo, Wang, Tao, Carreras, Jeanette, Deeg, H. Joachim, Ayas, Mouhab, Bajwa, Rajinder PS, George, Biju, Gupta, Vikas, Pasquini, Ricardo, Schrezenmeier, Hubert, Passweg, Jakob R., Schultz, Kirk R., Eapen, Mary
Publicado em 2012

In vivo T-cell depletion with myeloablative regimens on outcomes after cord blood transplantation for acute lymphoblastic leukemia in children

Por Ponce, Doris M., Eapen, Mary, Sparapani, Rodney, O'Brien, Tracey A., Chan, Ka Wah, Chen, Junfang, Craddock, John, Schultz, Kirk R., Wagner, John E., Perales, Miguel-Angel, Barker, Juliet N.
Publicado no Biol Blood Marrow Transplant (2015)

IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients

Por Pulsipher, Michael A., Carlson, Chris, Langholz, Bryan, Wall, Donna A., Schultz, Kirk R., Bunin, Nancy, Kirsch, Ilan, Gastier-Foster, Julie M., Borowitz, Michael, Desmarais, Cindy, Williamson, David, Kalos, Michael, Grupp, Stephan A.
Publicado no Blood (2015)

Risk Factors and Timing of Relapse after Allogeneic Transplantation in Pediatric ALL: For Whom and When should Interventions be Tested?

Por Pulsipher, Michael A., Langholz, Bryan, Wall, Donna A., Schultz, Kirk R., Bunin, Nancy, Carroll, William, Raetz, Elizabeth, Gardner, Sharon, Goyal, Rakesh K., Gastier-Foster, Julie, Borowitz, Michael, Teachey, David, Grupp, Stephan A.
Publicado no Bone Marrow Transplant (2015)

Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group

Por Fujii, Hisaki, Cuvelier, Geoff, She, Kevin, Aslanian, Soudabeh, Shimizu, Hiromi, Kariminia, Amina, Krailo, Mark, Chen, Zhengjia, McMaster, Rob, Bergman, Axel, Goldman, Frederick, Grupp, Stephen A., Wall, Donna A., Gilman, Andrew L., Schultz, Kirk R.
Publicado em 2008

One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers

Por Wagner, John E., Eapen, Mary, Carter, Shelly, Wang, Yanli, Schultz, Kirk R., Wall, Donna A., Bunin, Nancy, Delaney, Colleen, Haut, Paul, Margolis, David, Peres, Edward, Verneris, Michael R., Walters, Mark, Horowitz, Mary M., Kurtzberg, Joanne
Publicado no N Engl J Med (2014)

Poor Agreement between Clinician Response Ratings and Calculated Response Measures in Patients with Chronic Graft-versus-host Disease

Por Palmer, Jeanne M., Lee, Stephanie J., Chai, Xiaoyu, Storer, Barry E., Flowers, Mary ED, Schultz, Kirk R., Inamoto, Yoshihiro, Cutler, Corey, Pidala, Joseph, Arora, Mukta, Jacobsohn, David A., Carpenter, Paul A., Pavletic, Steven Z., Martin, Paul J.
Publicado em 2012

UNRELATED DONOR BONE MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME IN CHILDREN

Por Woodard, Paul, Carpenter, Paul A., Davies, Stella M., Gross, Thomas G., He, Wensheng, Zhang, Mei-Jie, Horn, Biljana N., Margolis, David A., Perentesis, John P., Sanders, Jean E., Schultz, Kirk R., Seber, Adriana, Woods, William G., Eapen, Mary
Publicado em 2010

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: III. The 2014 Biomarker Working Group Report

Por Paczesny, Sophie, Hakim, Frances T., Pidala, Joseph, Cooke, Kenneth, Lathrop, Julia, Griffith, Linda M., Hansen, John, Jagasia, Madan, Miklos, David, Pavletic, Steven, Parkman, Robertson, Russek-Cohen, Estelle, Flowers, Mary E.D., Lee, Stephanie, Martin, Paul, Vogelsang, Georgia, Walton, Marc, Schultz, Kirk R.
Publicado no Biol Blood Marrow Transplant (2015)

Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802

Por Holtan, Shernan G., Verneris, Michael R., Schultz, Kirk R., Newell, Laura F., Meyers, Gabrielle, He, Fiona, DeFor, Todd E., Vercellotti, Gregory M., Slungaard, Arne, MacMillan, Margaret L., Cooley, Sarah A., Blazar, Bruce R., Panoskaltsis-Mortari, Angela, Weisdorf, Daniel J.
Publicado no Biol Blood Marrow Transplant (2015)

Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observa...

Por McMahon, Kelly R., Rod Rassekh, Shahrad, Schultz, Kirk R., Pinsk, Maury, Blydt-Hansen, Tom, Mammen, Cherry, Tsuyuki, Ross T., Devarajan, Prasad, Cuvelier, Geoff D. E., Mitchell, Lesley G., Baruchel, Sylvain, Palijan, Ana, Carleton, Bruce C., Ross, Colin J. D., Zappitelli, Michael
Publicado no Can J Kidney Health Dis (2017)